The artificial pancreas is an ideal solution for intelligent diabetes management, but the R&D technical barriers are extremely high. Currently, no integrated mature product has achieved commercial launch worldwide. Leveraging our core proprietary electrochemical sensing technology, along with our advantages in miniaturization and low-cost R&D, we are developing an integrated, patch-type, dual-hormone, single-needle artificial pancreas. The product follows bionic design principles and incorporates our proprietary intelligent algorithm, enabling accurate prediction of glucose trends and personalized closed-loop regulation, providing an integrated, wearable, and precision diagnostic and therapeutic solution for diabetes.